Expression of infectious murine leukemia viruses by RAW264.7 cells, a potential complication for studies with a

Janet W Hartley1, Leonard H Evans, Kim Y Green

  • 1Laboratory of Immunopathology, NIAID, NIH, Bethesda, MD 20892, USA. jhartley@niaid.nih.gov

Retrovirology
|January 8, 2008
PubMed

Insights

The widely used RAW264.7 mouse macrophage cell line unexpectedly produces infectious murine leukemia virus (MuLV), posing risks for research. This viral contamination can lead to lymphoma in newborn mice, impacting various biological studies.

Area of Science:

  • Virology
  • Immunology
  • Cancer Research

Background:

  • The RAW264.7 cell line is a standard model for mouse macrophage research.
  • It was presumed to be free of replication-competent murine leukemia virus (MuLV).

Purpose of the Study:

  • To investigate the presence and characteristics of MuLV in currently available RAW264.7 cells.
  • To assess the pathogenic potential of the detected MuLV in vivo.

Main Methods:

  • Detection and characterization of retroviral particles produced by RAW264.7 cells.
  • Inoculation of newborn mice with the viral mixture to assess oncogenic potential.

Main Results:

  • RAW264.7 cells produce significant levels of ecotropic and polytropic/MCF-class MuLV.
  • Inoculation of newborn mice with this MuLV mixture resulted in lymphoma development.

Conclusions:

  • Current RAW264.7 cell lines harbor replication-competent MuLV, contrary to previous reports.
  • The presence of MuLV in RAW264.7 cells has critical implications for research using these cells, including viral propagation and studies of immune responses.

Related Concept Videos